Search research articles
Contact Us
Filters
Showing results (261-270 of 542) with videos related to
Page
of 55
Sort By:
Journal of Chemotherapy (Florence, Italy)
|
December 3, 2010
Telavancin Activity against gram-positive bacteria isolated from patients with skin and skin-structure infections
M A Pfaller, P R Rhomberg, H S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
April 29, 1998
National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic
M A Pfaller, R N Jones, S A Messer, et al.
Journal of Clinical Microbiology
|
June 6, 2007
Does one voriconazole breakpoint suit all Candida species?
Maiken Cavling Arendrup, David W Denning, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease
|
December 24, 1997
Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes
R N Jones, M A Pfaller, S A Marshall, et al.
Diagnostic Microbiology and Infectious Disease
|
January 8, 2000
Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridone
R N Jones, M E Erwin, D J Biedenbach, et al.
American Journal of Infection Control
|
June 1, 1995
The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study
S Lam, C Singer, V Tucci, et al.
Diagnostic Microbiology and Infectious Disease
|
May 5, 2000
Frequency of occurrence and antimicrobial susceptibility patterns for pathogens isolated from latin american patients with a diagnosis of pneumonia: results from the SENTRY antimicrobial surveillance program (1998)
M T Lewis, A C Gales, H S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2002
Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods
A L Barry, M A Pfaller, R P Rennie, et al.
Diagnostic Microbiology and Infectious Disease
|
June 23, 2000
Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species
D M Johnson, D J Biedenbach, M L Beach, et al.
Diagnostic Microbiology and Infectious Disease
|
June 23, 2000
Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
R N Jones, M A Croco, K C Kugler, et al.
Page
of 55
Search research articles
Search
Showing results (261-270 of 542) with videos related to
Sort By:
Page
of 55
Journal of Chemotherapy (Florence, Italy)
|
December 3, 2010
Telavancin Activity against gram-positive bacteria isolated from patients with skin and skin-structure infections
M A Pfaller, P R Rhomberg, H S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
April 29, 1998
National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic
M A Pfaller, R N Jones, S A Messer, et al.
Journal of Clinical Microbiology
|
June 6, 2007
Does one voriconazole breakpoint suit all Candida species?
Maiken Cavling Arendrup, David W Denning, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease
|
December 24, 1997
Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes
R N Jones, M A Pfaller, S A Marshall, et al.
Diagnostic Microbiology and Infectious Disease
|
January 8, 2000
Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridone
R N Jones, M E Erwin, D J Biedenbach, et al.
American Journal of Infection Control
|
June 1, 1995
The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study
S Lam, C Singer, V Tucci, et al.
Diagnostic Microbiology and Infectious Disease
|
May 5, 2000
Frequency of occurrence and antimicrobial susceptibility patterns for pathogens isolated from latin american patients with a diagnosis of pneumonia: results from the SENTRY antimicrobial surveillance program (1998)
M T Lewis, A C Gales, H S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2002
Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods
A L Barry, M A Pfaller, R P Rennie, et al.
Diagnostic Microbiology and Infectious Disease
|
June 23, 2000
Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species
D M Johnson, D J Biedenbach, M L Beach, et al.
Diagnostic Microbiology and Infectious Disease
|
June 23, 2000
Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
R N Jones, M A Croco, K C Kugler, et al.
Page
of 55